Jordan J Jones
Overview
Explore the profile of Jordan J Jones including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jones J, Jones K, Wong S, Whittle J, Goode D, Nguyen H, et al.
Neurooncol Adv
. 2024 Apr;
6(1):vdae041.
PMID: 38596716
Background: Liquid biopsy based on circulating tumor DNA (ctDNA) is a novel tool in clinical oncology, however, its use has been limited in glioma to date, due to low levels...
2.
Jones J, Nguyen H, Wong S, Whittle J, Iaria J, Stylli S, et al.
Neurooncol Adv
. 2024 Apr;
6(1):vdae027.
PMID: 38572065
Background: Circulating tumor DNA has emerging clinical applications in several cancers; however, previous studies have shown low sensitivity in glioma. We investigated if 3 key glioma gene mutations , ,...
3.
Moffet J, Fatunla O, Freytag L, Kriel J, Jones J, Roberts-Thomson S, et al.
Neurooncol Adv
. 2023 Dec;
5(1):vdad142.
PMID: 38077210
Background: High-grade gliomas (HGGs) are aggressive primary brain cancers with poor response to standard regimens, driven by immense heterogeneity. In isocitrate dehydrogenase () wild-type HGG (glioblastoma, GBM), increased intratumoral heterogeneity...
4.
Ma C, Nguyen H, Jones J, Stylli S, Whitehead C, Paradiso L, et al.
Int J Mol Sci
. 2022 Mar;
23(5).
PMID: 35269915
Glioblastoma is the most aggressive brain tumour with short survival, partly due to resistance to conventional therapy. Glioma stem cells (GSC) are likely to be involved in treatment resistance, by...
5.
Drummond K, Hunn B, McAlpine H, Jones J, Davies M, Gull S
Neurosurg Focus
. 2020 Mar;
48(3):E10.
PMID: 32114546
Objective: Neurosurgical training poses particular challenges in Australia and New Zealand, given the large landmass, small population, and widely separated, often small, neurosurgical units. Such factors have necessitated a move...
6.
Thuy M, Kam J, Lee G, Tao P, Ling D, Cheng M, et al.
J Clin Neurosci
. 2015 Feb;
22(5):785-99.
PMID: 25698544
Glioblastoma multiforme (GBM) has a poor prognosis despite maximal multimodal therapy. Biomarkers of relevance to prognosis which may also identify treatment targets are needed. A few hundred genetic and molecular...